Eric Swayze, EVP Research at IONIS PHARMACEUTICALS INC (IONS), sold 15,642 shares at $82.07 ($1.3M) on 2026-02-13, disclosed to the SEC on 2026-02-13.
Scheduled sale ($1.3M) by EVP Research under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.56 | 9,435 | $770K | 60.2% |
| 2 | $82.07 | 6,207 | $509K | 39.8% |
| Total | $81.76 avg | 15,642 | $1.3M | 100% |
| Filing → |
| IONS | SELL | 2026-01-20 | $748K | — | Filing → |
| IONS | SELL | 2026-01-06 | $1.9M | — | Filing → |
| IONS | SELL | 2025-10-16 | $4K | — | Filing → |